| __timestamp | Bio-Techne Corporation | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 357763000 | 11032000 |
| Thursday, January 1, 2015 | 452246000 | 4050000 |
| Friday, January 1, 2016 | 499023000 | 11043000 |
| Sunday, January 1, 2017 | 563003000 | 327000 |
| Monday, January 1, 2018 | 642993000 | 8198000 |
| Tuesday, January 1, 2019 | 714006000 | 35219000 |
| Wednesday, January 1, 2020 | 738691000 | 46551000 |
| Friday, January 1, 2021 | 931032000 | 439442000 |
| Saturday, January 1, 2022 | 1105599000 | 722683000 |
| Sunday, January 1, 2023 | 1136702000 | 232284000 |
| Monday, January 1, 2024 | 1159060000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, revenue growth is a key indicator of a company's success. Bio-Techne Corporation and Dynavax Technologies Corporation have been at the forefront of this industry, each with its unique trajectory. From 2014 to 2023, Bio-Techne's revenue surged by over 220%, showcasing a consistent upward trend. In contrast, Dynavax experienced a more volatile journey, with a remarkable spike in 2021, where revenue increased by nearly 900% compared to 2020, before stabilizing in subsequent years.
Bio-Techne's steady growth reflects its robust product portfolio and strategic acquisitions, while Dynavax's revenue peaks highlight its breakthrough innovations, particularly in vaccine development. However, the absence of data for Dynavax in 2024 suggests potential challenges or strategic shifts. As these companies continue to innovate, their financial trajectories offer valuable insights into the dynamic biotech landscape.
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Revenue Showdown: Sanofi vs Dynavax Technologies Corporation
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Bio-Techne Corporation vs Telix Pharmaceuticals Limited
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Telix Pharmaceuticals Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Who Generates More Revenue? ADMA Biologics, Inc. or Dynavax Technologies Corporation
Who Generates More Revenue? Geron Corporation or Dynavax Technologies Corporation
Who Generates More Revenue? Dynavax Technologies Corporation or Travere Therapeutics, Inc.